Diagnostic assessment of magnetic resonance imaging for patients with intralabyrinthine schwannoma: A systematic review

J Neuroradiol. 2022 Jan;49(1):41-46. doi: 10.1016/j.neurad.2020.08.002. Epub 2020 Aug 27.

Abstract

Objectives: Recent advancements in high-resolution imaging have improved the diagnostic assessment of magnetic resonance imaging (MRI) for intralabyrinthine schwannoma (ILS). This systematic review aimed to evaluate the diagnostic performance of MRI for patients with ILS.

Methods: Ovid-MEDLINE and EMBASE databases were searched for related studies on the diagnostic performance of MRI for patients with ILS published up to February 10, 2020. The primary endpoint was the diagnostic performance of MRI for ILS. The quality of the enrolled studies was assessed using tailored questionnaires and the Quality Assessment of Diagnostic Accuracy Studies-2 criteria.

Results: Overall, 6 retrospective studies that included 122 patients with ILS from a parent population of 364 were included. The sample size, parent population and its composition, reference standard, detailed parameters of MRI, and even the diagnostic methods varied between the studies. The studies had moderate quality. The sensitivity of combination of T2WI and CE-T1WI was over 90%. Relative sensitivity of T2WI comparative to CE-T1WI ranged from 62% to 100%, and the specificity were 100%.

Conclusions: MRI has acceptable diagnostic performance for ILS. There is a need for well-organized research to reduce the factors causing heterogeneity.

Keywords: Intralabyrinthine schwannoma; Magnetic resonance imaging; Systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Humans
  • Magnetic Resonance Imaging*
  • Neurilemmoma* / diagnostic imaging
  • Retrospective Studies
  • Sensitivity and Specificity